doctor, at the revolt is located treating the planet he gold;
knfpts at allwrite.be
Mon Oct 2 06:32:13 CDT 2006
HOT STOCK ALERT - THIS ONE IS STILL CLIMBING THE STOCK CHARTS ALERT --
BREAKING MARKET NEWS REPORT ---- PGCN.OB
Company: Pingchuan Pharmaceutical Inc.
Current Price: $.26
5-Day Target: $1.5 - $2
Recommendation: S T R 0 N G - B U Y !!
This quick rising stock is a good long term winner. This stock is
going high due to superb business solutions and creative partnerships
in the business world.
Could this company be the next PFIZER??
Pingchaun Pharmaceuticals disributes its medications to over 50
percent of CHINA and has a tremendous presence via exports to U.S.A,
Russia, Japan and South-Eastern Asia. They have partnerships with the
biggest drugstores, equivalent in the US to SAV-ON, CVS, RITE-AID,
etc. With BIG NEWS anticipated this coming WEEK we strongly advise
you to get in EARLY and issue
a 10/10 Alert.
About Pingchuan Pharmaceutical Inc.
Pingchuan Pharmaceutical Inc. ("PINGCHUAN") is a modernized
pharmaceutical manufacturer with first-class medical R&D ability,
pioneered medicine products, and well-established marketing network.
Since its establishment, PINGCHUAN has focused its businesses on
diabetes medicine and its medical products. The products of PINGCHUAN
include health care products, varieties of medicine, as well as
medical apparatus. Kang Da Glycosuria Capsule is a successful product
of PINGCHUAN for treating diabetes, which was first developed in 1998
and introduced to the market in 2001. PINGCHUAN has well-established
marketing network and sale branches, which include about 180,000
retail pharmacies /drugstores across China, agency network in major
cities like Beijing, Shanghai, Guangzhou, and Xi'an, special counter
sale at drug chain stores in key regions, residence community clinic
sale and promotion, as well as internet marketing through the
company's website. The marketing network of PINGCHUAN covers more than
50 percent districts
of China and exports to US, Japan, Russia, and south-eastern Asia.
Dont miss the boat, this is a new issue, is thinly traded and could
move up quickly. We anticipate that shares of PGCN will be much
higher in the short-term. ACT NOW!
Remember the gains from our recent recommendations... Do not miss out,
Put PGCN.OB on your radar's now. Good luck and trade out at the top!!
More information about the Numpy-discussion